findmyKOL
Clinical trialNCT00253747CompletedPhase 3Interventional

Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

SponsorUniversity of CincinnatiEnrollment255ADHDSmoking
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to evaluate whether Osmotic-Release Methylphenidate (OROS MPH), relative to placebo, increases the effectiveness of standard smoking treatment (i.e., nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence for smokers with Attention Deficit Hyperactivity Disorder (ADHD).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Massachusetts General Hospital

    Cambridge, Massachusetts, United States

  • Mayo Clinic Nicotine Research Program

    Rochester, Minnesota, United States

  • New York State Psychiatric Institute - Smoking Cessation Program

    New York, New York, United States

  • Va New York Harbor Healthcare System

    New York, New York, United States

  • Maryhaven, Inc.

    Columbus, Ohio, United States

  • Kaiser Permanente (center for Health Research)

    Portland, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Osmotic-Release MethylphenidatePlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2005
Primary completion
31 Jan 2008
Completion
31 Mar 2008
Last update posted
17 Sept 2012
Registered enrollment
255
Registry id
NCT00253747
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.